Andrew Pangilinan
About Andrew Pangilinan
Andrew Pangilinan is a Senior Manager at Clarify Health Solutions, specializing in Real World Evidence Clinical Research. He has extensive experience in management consulting within the healthcare and life sciences sectors, and holds advanced degrees in Epidemiology and Psychology.
Work at Clarify Health Solutions
Andrew Pangilinan serves as the Senior Manager of Life Sciences Solutions at Clarify Health Solutions. He has held this position since 2021 in New York, United States. In this role, he utilizes his expertise in Real World Evidence (RWD/RWE) Clinical Research to generate clinical evidence regarding the usage and potential benefits or risks of medical products.
Education and Expertise
Andrew Pangilinan holds a Master's degree in Epidemiology from Columbia University Mailman School of Public Health, where he studied from 2015 to 2017. He also earned a Bachelor of Arts in Psychology & Biology, Pre-Med from the University of Miami, studying from 2011 to 2013. Additionally, he studied Kinesiology and Exercise Science at The George Washington University from 2009 to 2011. His educational background supports his specialization in Epidemiological Research Methods and skills in Population Health and Statistical Data Analysis.
Background in Healthcare Consulting
Andrew has a background in management consulting within the healthcare and life sciences industries. He worked as a Strategy Consultant at IQVIA from 2019 to 2021, providing strategic advice to organizations. Prior to that, he served as a Research Project Coordinator at Memorial Sloan Kettering Cancer Center from 2018 to 2019, and as a Graduate Research Assistant at Columbia University Mailman School of Public Health from 2016 to 2017.
Research Experience
Andrew Pangilinan has extensive research experience in the healthcare field. He worked as a Research Associate at the University of Miami, Miller School of Medicine from 2013 to 2014. His roles have involved utilizing real-world data to inform clinical research and improve health outcomes, demonstrating his commitment to advancing knowledge in the life sciences.